SpectraCure AB (publ) (FRA:2OK)
Germany
· Delayed Price · Currency is EUR 0.0056
+0.0003 (5.66%)
At close: Dec 5, 2025
SpectraCure AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Other Revenue | - | - | - | 0.54 | - | 1.21 | Upgrade
|
| Revenue | - | - | - | 0.54 | - | 1.21 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 58.72% | Upgrade
|
| Cost of Revenue | -10.45 | -9.77 | -9.54 | -3.05 | -1.39 | -2.35 | Upgrade
|
| Gross Profit | 10.45 | 9.77 | 9.54 | 3.59 | 1.39 | 3.56 | Upgrade
|
| Selling, General & Admin | 33.02 | 31.62 | 30.91 | 28.72 | 27.76 | 20.49 | Upgrade
|
| Other Operating Expenses | 0.17 | -1.39 | -2.5 | -2.32 | -5.71 | -3.89 | Upgrade
|
| Operating Expenses | 63.37 | 32.86 | 31.07 | 29.27 | 24.71 | 18.88 | Upgrade
|
| Operating Income | -52.92 | -23.1 | -21.53 | -25.69 | -23.33 | -15.32 | Upgrade
|
| Interest Expense | -1.3 | -0.47 | -0.52 | -0.18 | -0.25 | -0.28 | Upgrade
|
| Interest & Investment Income | 1.21 | 1.21 | 1.95 | 0.54 | 0.22 | 0.16 | Upgrade
|
| Earnings From Equity Investments | -0.18 | -0.69 | -0.54 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.06 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -53.14 | -23.01 | -20.59 | -25.33 | -23.36 | -15.44 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.12 | 0.02 | 0.01 | - | Upgrade
|
| Asset Writedown | - | - | - | -0.06 | - | - | Upgrade
|
| Pretax Income | -53.14 | -23.01 | -20.46 | -25.38 | -23.35 | -15.44 | Upgrade
|
| Income Tax Expense | 0.03 | -0.01 | -0.02 | - | -0.01 | -0.03 | Upgrade
|
| Net Income | -53.17 | -23 | -20.44 | -25.38 | -23.34 | -15.41 | Upgrade
|
| Net Income to Common | -53.17 | -23 | -20.44 | -25.38 | -23.34 | -15.41 | Upgrade
|
| Shares Outstanding (Basic) | 205 | 97 | 97 | 97 | 97 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 205 | 97 | 97 | 97 | 97 | 92 | Upgrade
|
| Shares Change (YoY) | 110.83% | - | - | - | 5.11% | 12.18% | Upgrade
|
| EPS (Basic) | -0.26 | -0.24 | -0.21 | -0.26 | -0.24 | -0.17 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.24 | -0.21 | -0.26 | -0.24 | -0.17 | Upgrade
|
| Free Cash Flow | -24.6 | -21.25 | -18.68 | -23.52 | -18.77 | -9.84 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.22 | -0.19 | -0.24 | -0.19 | -0.11 | Upgrade
|
| Gross Margin | - | - | - | 665.12% | - | 294.06% | Upgrade
|
| Operating Margin | - | - | - | -4766.05% | - | -1264.99% | Upgrade
|
| Profit Margin | - | - | - | -4708.53% | - | -1272.25% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -4363.82% | - | -812.47% | Upgrade
|
| EBITDA | -24.96 | -22.68 | -21.03 | -25.18 | -22.87 | -14.93 | Upgrade
|
| D&A For EBITDA | 27.96 | 0.42 | 0.51 | 0.51 | 0.46 | 0.39 | Upgrade
|
| EBIT | -52.92 | -23.1 | -21.53 | -25.69 | -23.33 | -15.32 | Upgrade
|
| Revenue as Reported | 1.42 | 1.53 | 2.84 | 2.94 | 5.75 | 5.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.